Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression

Curation statements for this article:
  • Curated by eLife

    eLife logo

    eLife assessment

    This valuable paper compares blood gene signature responses between small cohorts of individuals with mild and severe COVID-19 and claims that an early innate immune response mediated via NK cells leads to less severe infection, more rapid viral clearance, and Th1/2 differentiation. The evidence supporting the conclusions is solid based on the use of appropriate and comprehensive assays and analysis tools, but not definitive based on mismatched timing of samples between the two cohorts coupled with small cohort size.

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

Patients present a wide range of clinical severities in response SARS-CoV-2 infection, but the underlying molecular and cellular reasons why clinical outcomes vary so greatly within the population remains unknown. Here, we report that negative clinical outcomes in severely ill patients were associated with divergent RNA transcriptome profiles in peripheral immune cells compared with mild cases during the first weeks after disease onset. Protein-protein interaction analysis indicated that early-responding cytotoxic NK cells were associated with an effective clearance of the virus and a less severe outcome. This innate immune response was associated with the activation of select cytokine-cytokine receptor pathways and robust Th1/Th2 cell differentiation profiles. In contrast, severely ill patients exhibited a dysregulation between innate and adaptive responses affiliated with divergent Th1/Th2 profiles and negative outcomes. This knowledge forms the basis of clinical triage that may be used to preemptively detect high-risk patients before life-threatening outcomes ensue. – Mild COVID-19 patients presented an early compromise with NK cell function, whereas severe patients do so with neutrophil function. – The identified co-expressed genes give insights into a coordinated transcriptional program of NK cell cytotoxic activity being associated with mild patients. – Key checkpoints of NK cell cytotoxicity that were enriched in mild patients include: KLRD1 , CD247 , and IFNG . – The early innate immune response related to NK cells connects with the Th1/Th2 adaptive immune responses, supporting their relevance in COVID-19 progression.

Article activity feed

  1. eLife assessment

    This valuable paper compares blood gene signature responses between small cohorts of individuals with mild and severe COVID-19 and claims that an early innate immune response mediated via NK cells leads to less severe infection, more rapid viral clearance, and Th1/2 differentiation. The evidence supporting the conclusions is solid based on the use of appropriate and comprehensive assays and analysis tools, but not definitive based on mismatched timing of samples between the two cohorts coupled with small cohort size.

  2. Reviewer #1 (Public Review):

    Summary:
    Medina et al, 2023 investigated the peripheral blood transcriptional responses in patients with diversifying disease outcomes. The authors characterized the blood transcriptome of four non-hospitalized individuals presenting mild disease and four patients hospitalized with severe disease. These individuals were observed longitudinally at three time points (0-, 7-, and 28-days post recruitment), and distinct transcriptional responses were observed between severe hospitalized patients and mild non-hospitalized individuals, especially during 0- and 7-day collection time points. Particularly, the authors found that increased expression of genes associated with NK cell cytotoxicity is associated with mild outcomes. Additional co-regulated gene network analyses positively correlate T cell activity with mild disease and neutrophil degranulation with severe disease.

    Strengths:
    The longitudinal measurements in individual participants at consistent collection intervals can offer an added dimension to the dataset that involves temporal trajectories of genes associated with disease outcomes and is a key strength of the study. The use of co-expressed gene networks specific to the cohort to complement enrichment results obtained from pre-determined genesets can offer valuable insights into new associations/networks associated with disease progression and warrants further analyses on the biological functions enriched within these co-expressed network modules.

    Weaknesses:
    There is a large difference in terms of infection timeline (onset of symptom to recruitment) between mild and severe patient cohorts. As immune responses during early infection can be highly dynamic, the differences in infection timeline may contribute to differences in transcriptional signatures. The study is also limited by a small cohort size.

  3. Reviewer #2 (Public Review):

    In their manuscript, Medina and colleagues investigate transcriptional differences between mild and severe SARS-CoV-2 infections. Their analyses are very comprehensive incorporating a multitude of bioinformatics tools ranging from PCA plots, GSEA and DEG analysis, protein-protein interaction network, and weighted correlation network analyses. They conclude that in mild COVID-19 infection NK cell functionality is compromised and this is connected to cytokine interactions and Th1/Th2 cell differentiation pathways cross-talk, bridging the innate and the adaptive arms of the immune system.

    The authors successfully recruited participants with both mild and severe COVID-19 between November 2020 to May 2021. The analyzed cohort is gender and acceptably age-matched and the results reported are promising. Signatures associated with NK cell cytotoxicity in mild and neutrophil functions in the severe group during acute infection are the chief findings reported in this manuscript.

  4. Reviewer #3 (Public Review):

    Summary:
    Medina and colleagues explored transcriptional kinetics during SARS-CoV-2 between non-hospitalized and hospitalized cohorts and identified that early NK signaling may be responsible for less severe disease.

    Strengths:
    The paper includes extremely detailed analyses and makes an interesting attempt to link innate and adaptive responses. The analyses are appropriate for the data and described in clear language. The inclusion of late time points is interesting and potentially relevant to long COVID studies. Most findings were compatible with other detailed immune mapping during severe COVID-19.

    Weaknesses:
    1. The authors claim to be looking at the earliest stages of infection but this is not true as all patients enrolled are already symptomatic. The time points selected are unlikely to be useful clinically for biomarker selection as they are too late, and are likely beyond the point when the immune responses between severe and mild infection start to diverge.
    2. The comparator timepoints between mild and severe cases do not match. The most comparison would be between day 7 of mild versus day 0 of severe which is already fairly late during infection.
    3. The authors mention viral clearance but I see no evidence of viral loads measured in these individuals.
    4. The cohort is quite small to draw definitive conclusions.
    5. It is uncertain whether the results are applicable to current conditions as most infected people are immune experienced.
    6. I found the discussion to be a bit too detailed and dense. I would suggest editing to make it more streamlined.